Arkolith/Insider Trading/BTCY/Form 4

Ayanoglou John

Chief Financial OfficerBIOTRICITY INC. (BTCY) · full profile →Form 4 · filed Mar 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
22
0 non-derivative · 22 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 31, 2022Grant(A)219K—$01.3M
Sep 30, 2022Grant(A)118K—$01.1M
Jun 30, 2022Grant(A)54K—$0991K
Mar 31, 2022Grant(A)38K—$0938K
Dec 31, 2021Grant(A)50K—$0900K
Sep 30, 2021Grant(A)50K—$0850K
Jun 30, 2021Grant(A)50K—$0800K
Mar 31, 2021Grant(A)50K—$0750K
Dec 31, 2020Grant(A)50K—$0700K
Sep 30, 2020Grant(A)50K—$0600K
Jun 30, 2020Grant(A)50K—$0550K
Mar 31, 2020Grant(A)50K—$0500K
Jan 24, 2020Grant(A)50K—$0650K
Dec 31, 2019Grant(A)50K—$0450K
Sep 30, 2019Grant(A)50K—$0400K
Jun 30, 2019Grant(A)50K—$0350K
Mar 31, 2019Grant(A)50K—$0300K
Dec 31, 2018Grant(A)50K—$0250K
Sep 30, 2018Grant(A)50K—$0200K
Jun 30, 2018Grant(A)50K—$0150K
Mar 31, 2018Grant(A)50K—$0100K
Oct 26, 2017Grant(A)50K—$050K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-007404) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML